Search research articles
Contact Us
Filters
Showing results (91-100 of 124) with videos related to
Page
of 13
Sort By:
Transplantation and Cellular Therapy
|
March 30, 2021
Incidence and Management of Effusions Before and After CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy in Large B Cell Lymphoma
Abu-Sayeef Mirza, Ambuj Kumar, Hamza Hashmi, et al.
Blood Advances
|
July 24, 2020
High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphoma
Erin A Dean, Rahul S Mhaskar, Hong Lu, et al.
The Journal of Clinical Investigation
|
October 30, 2025
IFN-γ-driven skewing towards Th1 over Th17 differentiation underlies CRS and neutropenia in CAR-T therapy
Payal Goala, Yongliang Zhang, Nolan Beatty, et al.
International Journal of Molecular Sciences
|
May 7, 2025
Intravenous Immunoglobulin (IVIG) for Patients with Severe Neurotoxicity Associated with Chimeric Antigen Receptor T-Cell (CAR-T) Therapy
Sepideh Mokhtari, Justin M Asquith, Syeda Saba Kareem, et al.
The Lancet. Haematology
|
February 10, 2023
CYAD-01, an autologous NKG2D-based CAR T-cell therapy, in relapsed or refractory acute myeloid leukaemia and myelodysplastic syndromes or multiple myeloma (THINK): haematological cohorts of the dose escalation segment of a phase 1 trial
David A Sallman, Tessa Kerre, Violaine Havelange, et al.
Molecular Therapy. Methods & Clinical Development
|
September 14, 2018
Screening Clinical Cell Products for Replication Competent Retrovirus: The National Gene Vector Biorepository Experience
Kenneth Cornetta, Lisa Duffy, Steven A Feldman, et al.
Transplantation and Cellular Therapy
|
March 30, 2021
ELN 2017 Genetic Risk Stratification Predicts Survival of Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation
Doris K Hansen, Jongphil Kim, Zachary Thompson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 23, 2021
Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results
Joseph Pidala, Kelly Walton, Hany Elmariah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 9, 2023
Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality
Shernan G Holtan, Constanza Savid-Frontera, Kelly Walton, et al.
Cardio-Oncology (London, England)
|
April 3, 2023
Cardiac and inflammatory biomarker differences in adverse cardiac events after chimeric antigen receptor T-Cell therapy: an exploratory study
Dae Hyun Lee, Sanjay Chandrasekhar, Michael D Jain, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 124) with videos related to
Sort By:
Page
of 13
Transplantation and Cellular Therapy
|
March 30, 2021
Incidence and Management of Effusions Before and After CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy in Large B Cell Lymphoma
Abu-Sayeef Mirza, Ambuj Kumar, Hamza Hashmi, et al.
Blood Advances
|
July 24, 2020
High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphoma
Erin A Dean, Rahul S Mhaskar, Hong Lu, et al.
The Journal of Clinical Investigation
|
October 30, 2025
IFN-γ-driven skewing towards Th1 over Th17 differentiation underlies CRS and neutropenia in CAR-T therapy
Payal Goala, Yongliang Zhang, Nolan Beatty, et al.
International Journal of Molecular Sciences
|
May 7, 2025
Intravenous Immunoglobulin (IVIG) for Patients with Severe Neurotoxicity Associated with Chimeric Antigen Receptor T-Cell (CAR-T) Therapy
Sepideh Mokhtari, Justin M Asquith, Syeda Saba Kareem, et al.
The Lancet. Haematology
|
February 10, 2023
CYAD-01, an autologous NKG2D-based CAR T-cell therapy, in relapsed or refractory acute myeloid leukaemia and myelodysplastic syndromes or multiple myeloma (THINK): haematological cohorts of the dose escalation segment of a phase 1 trial
David A Sallman, Tessa Kerre, Violaine Havelange, et al.
Molecular Therapy. Methods & Clinical Development
|
September 14, 2018
Screening Clinical Cell Products for Replication Competent Retrovirus: The National Gene Vector Biorepository Experience
Kenneth Cornetta, Lisa Duffy, Steven A Feldman, et al.
Transplantation and Cellular Therapy
|
March 30, 2021
ELN 2017 Genetic Risk Stratification Predicts Survival of Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation
Doris K Hansen, Jongphil Kim, Zachary Thompson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 23, 2021
Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results
Joseph Pidala, Kelly Walton, Hany Elmariah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 9, 2023
Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality
Shernan G Holtan, Constanza Savid-Frontera, Kelly Walton, et al.
Cardio-Oncology (London, England)
|
April 3, 2023
Cardiac and inflammatory biomarker differences in adverse cardiac events after chimeric antigen receptor T-Cell therapy: an exploratory study
Dae Hyun Lee, Sanjay Chandrasekhar, Michael D Jain, et al.
Page
of 13